Ren Xiang Tan

Dr. Ren Xiang Tan

State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2008 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
YZYing Lao Zhang
Ying Lao Zhang
HGHui Ming Ge
Hui Ming Ge
WZWei Zhao
Wei Zhao
HDHao Dong
Hao Dong
QXQiang Xu
Qiang Xu
Ren Xiang TanRen Xiang Tan
Ren Xiang Tan

12 November 2015 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
LKLing Yi Kong
Ling Yi Kong
Ren Xiang TanRen Xiang Tan
Ren Xiang Tan
The background information about the discovery of artemisinin-based antimalarials is provided along with authors' viewpoint towards the extractability of modern medicines from natural products.

17 December 2007 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
HGHui Ming Ge
Hui Ming Ge
CZChun Hua Zhu
Chun Hua Zhu
DSDa Hua Shi
Da Hua Shi
LZLi Dong Zhang
Li Dong Zhang
DXDai Qian Xie
Dai Qian Xie
Ren Xiang TanRen Xiang Tan
Ren Xiang Tan

24 March 2011 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YZYing L. Zhang
Ying L. Zhang
JZJie Zhang
Jie Zhang
NJNan Jiang
Nan Jiang
YLYan H. Lu
Yan H. Lu
LWLu Wang
Lu Wang
Ren Xiang TanRen Xiang Tan
Ren Xiang Tan

13 March 2019 in Nature
Verified
Journal Article
Closed access
PDF file
BZBo Zhang
Bo Zhang
KWKai Biao Wang
Kai Biao Wang
WWWen Wang
Wen Wang
XWXin Wang
Xin Wang
FLFang Liu
Fang Liu
HGHuiming Ge
Huiming Ge

21 October 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HSHengfei Shi
Hengfei Shi
KRKe Ren
Ke Ren
BLBaojie Lv
Baojie Lv
WZWei Zhang
Wei Zhang
YZYing Zhao
Ying Zhao
ELErguang Li
Erguang Li
The roots of Scutellaria baicalensis has been used as a remedy for inflammatory and infective diseases for thousands of years. We evaluated the antiviral activity against respiratory syncytial virus (RSV) infection, the leading cause of childhood infection and hospitalization. By fractionation and chromatographic analysis, we determined that baicalin was responsible for the antiviral activity of S. baicalensis against RSV infection. The concentration for 50% inhibition (IC50) of RSV infection was determined at 19.9 ± 1.8 μM, while the 50% cytotoxic concentration (CC50) was measured at 370 ± 10 μM. We then used a mouse model of RSV infection to further demonstrate baicalin antiviral effect. RSV infection caused significant lung injury and proinflammatory response, including CD4 and CD8 T lymphocyte infiltration. Baicalin treatment resulted in reduction of T lymphocyte infiltration and gene expression of proinflammatory factors, while the treatment moderately reduced RSV titers recovered from the lung tissues. T lymphocyte infiltration and cytotoxic T lymphocyte modulated tissue damage has been identified critical factors of RSV disease. The study therefore demonstrates that baicalin subjugates RSV disease through antiviral and anti-inflammatory effect.